cabozantinib
exelixis
['atlantis', 'cabozantinib']
a randomized, double-blind, pii clinical trial of maintenance cabozantinib following chemotherapy for #muc: final analysis of the #atlantis cabozantinib comparison. presented by robert jones, md. #asco coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology